RT info:eu-repo/semantics/article
T1 Pharmaceuticals in Water: Risks to Aquatic Life and Remediation Strategies
A1 Khan, Aqib Hassan Ali
A1 Barros García, Rocío
K1 Pharmaceuticals
K1 aquatic ecosystems
K1 Hydrobiology
K1 Phytoremediation
K1 Advance oxidative processes
K1 Bioquímica
K1 Biochemistry
K1 Microbiología
K1 Microbiology
AB The presence of pharmaceuticals in the aquatic environment presents a challenge to modern science. The most significant impact this can induce is the emergence of antibiotic resistance, which can lead to a global health emergency. It is important to note that the impact of pharmaceuticals in the aquatic environment is not limited to antibiotic resistance. Pharmaceuticals can also affect the behaviour and reproductive systems of aquatic organisms, with cascading effects on entire ecosystems. Numerous studies have reported the emergence of pharmaceuticals due to the uncontrolled disposal of polluted domestic, agricultural, and industrial wastewater in water bodies. This work discusses the potential of pharmaceuticals that on one hand are highly important for mankind, yet their non-judicious usage and disposal induce equally intriguing and problematic conditions to the health of aquatic systems. Pathways through which pharmaceutics can make their way into water bodies are discussed. Furthermore, the risk imposed by pharmaceuticals on aquatic life is also elaborated. The possible and pragmatic remediation methods through which pharmaceutical products can be treated are also discussed. Emphasis is placed on the potential of phytoremediation and advanced oxidative process, and the factors affecting the efficacy of these remediation methods are discussed.
PB MDPI
SN 2673-9917
YR 2023
FD 2023-06
LK http://hdl.handle.net/10259/7719
UL http://hdl.handle.net/10259/7719
LA eng
NO This article belongs to the Special Issue "Feature Papers in Hydrobiology 2022–2023"
NO The authors want to acknowledge the funding received under GREENER and BIOSYSMO projects. The GREENER project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Grant Agreement No. 826312, while the BIOSYSMO project is funded by the European Union under the Grant Agreement No. 101060211.
DS Repositorio Institucional de la Universidad de Burgos
RD 10-may-2024